Latest News

  • Proove Releases Predictive Pharmacogenetic Tests for Addiction, Fibromyalgia, Thromboembolism

    Diagnostics World | Proove Biosciences has added three new tests to its line of genetic profiles that help physicians make better decisions about how to treat illnesses. The new profiles for addiction, fibromyalgia, and thromboembolism are designed to identify specific genetic markers and other factors that are unique to each patient and influence that patient's response to different treatments. Physicians in private, university, and public healthcare centers can use this information to make more informed decisions regarding treatment on an individual basis.

    Aug 15, 2016

  • Speeding Diagnosis for Newborns with Liver Disease

    Diagnostics World | Doctors at Baylor College of Medicine and Texas Children’s Hospital report a way to detect biliary atresia and other neonatal liver diseases in newborns with a blood test.

    Aug 10, 2016

  • Big Driver of Medicare Spending Doctors Doing More Tests in Their Offices

    WSJ | Government Medicare payouts rise when new medical devices allow doctors to test patients in their own offices, the latest data show.

    Aug 10, 2016

  • Quest Diagnostics Introduces Digital Cognitive Assessment Tool

    News Medical | The new CogniSense tool from Quest Diagnostics, available as an iPad app, provides standard tests for assessing patients with dementia, in a format that can be tracked over time and integrated into electronic medical records.

    Aug 9, 2016

  • Zoetis Purchases Lab-on-Chip Company for Veterinary Diagnostics

    Diagnostics World News Brief | Zoetis, a veterinary medicine company, has acquired Denmark-based Scandinavian Micro Biodevices in an $80 million deal to develop new point-of-care diagnostic devices for use with pets and livestock.

    Aug 8, 2016

  • Bristol-Myers Squibbs Defeat Is A Victory For Personalized Medicine

    Forbes | Bristol-Myers Squibb Company stock price fell 16% after its breakthrough cancer drug, Opdivo, failed to slow tumor growth in previously untreated patients with non-small cell lung cancer. The reason why may be a diagnostic test.

    Aug 6, 2016

  • Why The World Needs An Essential Diagnostics List

    Forbes | Without diagnostics, medicine is blind. And yet, diagnostics receive much less attention than vaccines and drugs.

    Aug 5, 2016

  • Diagnostics at Home: Mately Uses Blood Spots to Track STDs

    Diagnostics World | Healthcare innovation is connecting with patients in ways that are easily accessible, low cost, and convenient. Mately is doing that via a new, at-home, sexually transmitted disease (STD) screening system.

    Aug 4, 2016

  • Foundation Medicine Announces FDA, CMS Parallel Review

    Diagnostics World Brief | Foundation Medicine announced that the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have accepted FoundationOne for Parallel Review as an innovative technology most likely to benefit from the efficiencies of this program. The FDA also accepted Foundation Medicine’s request for review as part of its Expedited Access Pathway (EAP) for breakthrough devices.

    Aug 2, 2016

  • Theranos Presents Data On New Blood Test Machine Remains Mum On Previous Technology

    Forbes | Elizabeth Holmes, the company's charismatic founder and chief executive, will show scientists details of a new device called the miniLab system, as well as results for tests done with it, but the data presented have no direct bearing on the tests that got Theranos in hot water with regulators.

    Aug 1, 2016

  • Theranos' Hail Mary Pass A Tabletop Laboratory

    CNN | CEO Elizabeth Homes will speak this afternoon at the American Association for Clinical Chemistry conference, and is expected to unveil a new product that promises to miniaturize lab analysis.

    Aug 1, 2016

  • New Zika Diagnostics, Image Analysis Updates: News and Briefs

    Diagnostics World Briefs | News and product launches from diagnostics technologies, bio IT, and clinical IT include new Zika diagnostics, more funding for N-of-One, and image analysis software.

    Aug 1, 2016

  • Theranos promises first peek at the science of its blood tests

    STAT | The embattled blood-testing company's CEO, Elizabeth Holmes, is drawing skepticism as she prepares to present data at a scientific conference Monday.

    Jul 29, 2016

  • The Case for Whole Gene Sequencing in Newborns

    Diagnostics World | Researchers mining data in California’s cystic fibrosis (CF) newborn screening registry have identified an additional mutation that is linked to later onset disease, but is usually missed in newborn screening. There is room for improvement, and CF is a particularly strong testbed.

    Jul 28, 2016

  • LabCorp Boosts Prenatal Testing Presence with $371M Sequenom Deal

    Xconomy | LabCorp, already a giant in diagnostics and laboratory testing, is building its capabilities in prenatal testing with an agreement to acquire Sequenom in a a $371 million deal.

    Jul 27, 2016

  • A Sniff Test For Alzheimers Checks For The Ability To Identify Odors Shots

    NPR.org | New research suggests it may be possible to spot people in the early stages of Alzheimer's by testing their ability to recognize fragrances. The goal is a quick and inexpensive screening test.

    Jul 26, 2016

  • Craig Venter’s Latest Production

    MIT Technology Review | With more data, a pioneer of gene sequencing hopes to unlock the connections between DNA and illness.

    Jul 25, 2016